Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Eosinophilic inflammation in COPD: prevalence and clinical characteristics

Dave Singh, Umme Kolsum, Chris E. Brightling, Nicholas Locantore, Alvar Agusti, Ruth Tal-Singer on behalf of the ECLIPSE investigators
European Respiratory Journal 2014 44: 1697-1700; DOI: 10.1183/09031936.00162414
Dave Singh
1University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umme Kolsum
1University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ukolsum@meu.org.uk
Chris E. Brightling
2Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Locantore
3GlaxoSmithKline, Research and Development, Research Triangle Park, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvar Agusti
4Fundació Investigació Sanitària Illes Balears (FISIB), Centro de investigación biomedical en red de enfermedades respiratorias (CIBERES), Palma de Mallorca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Tal-Singer
5GlaxoSmithKline, Research and Development, King of Prussia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 6 1697-1700
DOI 
https://doi.org/10.1183/09031936.00162414
PubMed 
25323230

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received June 30, 2014
  • Accepted September 4, 2014
  • Published online November 30, 2014.

Article Versions

  • previous version (October 16, 2014 - 07:40).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©ERS 2014

Author Information

  1. Dave Singh1,
  2. Umme Kolsum1⇑,
  3. Chris E. Brightling2,
  4. Nicholas Locantore3,
  5. Alvar Agusti4 and
  6. Ruth Tal-Singer5
  7. on behalf of the ECLIPSE investigators
  1. 1University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK
  2. 2Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
  3. 3GlaxoSmithKline, Research and Development, Research Triangle Park, NC, USA
  4. 4Fundació Investigació Sanitària Illes Balears (FISIB), Centro de investigación biomedical en red de enfermedades respiratorias (CIBERES), Palma de Mallorca, Spain
  5. 5GlaxoSmithKline, Research and Development, King of Prussia, PA, USA
  1. Umme Kolsum, University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Southmoor Road, Manchester, M23 9QZ, UK. E-mail: ukolsum{at}meu.org.uk
View Full Text

Article usage

Article usage: October 2014 to December 2022

AbstractFullPdf
Oct 2014980122
Nov 20141671199
Dec 201438291183
Jan 2015705468
Feb 20151106462
Mar 2015933648
Apr 20151133748
May 20151002339
Jun 2015953353
Jul 20151163045
Aug 20151004658
Sep 20151933037
Oct 201541211375
Nov 20154067785
Dec 20154224342
Jan 20163244750
Feb 20162392952
Mar 201641537173
Apr 201636926159
May 201632550110
Jun 201619298142
Jul 201610384112
Aug 201615196118
Sep 2016145104101
Oct 2016136124125
Nov 2016131133114
Dec 20161049672
Jan 2017113126107
Feb 20179610275
Mar 2017114165110
Apr 20171068676
May 2017110101120
Jun 20171088891
Jul 201710510180
Aug 201710110288
Sep 201784168111
Oct 2017114186197
Nov 2017147247173
Dec 20177418296
Jan 201858182114
Feb 201855187116
Mar 2018104222153
Apr 201858169109
May 20187318596
Jun 201853205104
Jul 20184120596
Aug 20181815657
Sep 201843165104
Oct 201835231100
Nov 201839172103
Dec 20181815583
Jan 201936288115
Feb 201937316124
Mar 201934376180
Apr 201933294119
May 20192731671
Jun 201928325136
Jul 201921394128
Aug 201932334121
Sep 201935441126
Oct 201921361112
Nov 20193631388
Dec 20192625474
Jan 20204422768
Feb 202033290113
Mar 20202628893
Apr 202049422104
May 20202832686
Jun 20202435493
Jul 20201738952
Aug 20202725650
Sep 20203830874
Oct 20204329091
Nov 20202726587
Dec 20203525963
Jan 20212930077
Feb 20212028271
Mar 202148308143
Apr 20213731179
May 20213432781
Jun 20211823752
Jul 20211918863
Aug 20211821840
Sep 20212625749
Oct 202128284106
Nov 202131293112
Dec 20213218142
Jan 20222030774
Feb 20222923758
Mar 20223128564
Apr 20223527768
May 20223725392
Jun 20221522170
Jul 20222421354
Aug 20223425860
Sep 20222024351
Oct 20223924392
Nov 20221627750
Dec 20221611934

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 44 Issue 6 Table of Contents
European Respiratory Journal: 44 (6)
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
Dave Singh, Umme Kolsum, Chris E. Brightling, Nicholas Locantore, Alvar Agusti, Ruth Tal-Singer
European Respiratory Journal Dec 2014, 44 (6) 1697-1700; DOI: 10.1183/09031936.00162414

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
Dave Singh, Umme Kolsum, Chris E. Brightling, Nicholas Locantore, Alvar Agusti, Ruth Tal-Singer
European Respiratory Journal Dec 2014, 44 (6) 1697-1700; DOI: 10.1183/09031936.00162414
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Impact of depression and anxiety on exacerbation risk in bronchiectasis
  • Respiratory management of drowning-associated ARF
  • Mitochondrial DNA as biomarker of survival in RA-ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society